Skip to content

AptarGroup ATR Share Buybacks

Share Buybacks at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$297.6M+123%
Amcor logo
AmcorAMCR
$0
Nordson logo
NordsonNDSN
$43.3M-49.7%
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
$60M+456%
United Therapeutics logo
United TherapeuticsUTHR
$1.5B
AVT
AvantorAVTR

Other financials

Income statement

See full
Revenue$982.9M+10.8%
Gross profit$351.9M+4.6%
Operating income$107.5M-5.2%
Net income$72.7M-7.8%
EPS (diluted)$1.12-4.3%

Balance sheet

See full
Cash & equivalents$225.0M+78.8%
Total debt$1.4B+32.7%
Total equity$2.6B+3.6%
Total assets$5.1B+12.6%

Cash flow

See full
Operating cash flow$118.7M+43.5%
CapEx$65.4M+15.0%
Free cash flow$53.3M+106%

Valuation

See full
Market cap$7.68B-17.9%
Enterprise value$8.89B-13.9%
P/E19.9×-5.4×
P/S-0.6×

Profitability

See full
Gross margin36.7%-1.6pp
Operating margin12.8%-1.2pp
Net margin10%-0.4pp
FCF margin8.4%-2.1pp

Returns & leverage

See full
Return on equity15%-0.2pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.4×

Where this comes from

Reported directly by AptarGroup in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The official record: AptarGroup’s 10-Q, filed May 1, 2026, on SEC EDGAR. View the filing →

Ask your AI about AptarGroup's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AptarGroup's share buybacks?
AptarGroup (ATR) reported share buybacks of $99.97M in Q1 2026.
How has AptarGroup's share buybacks changed year-over-year?
AptarGroup's share buybacks increased by 25.0% year-over-year, from $80M to $99.97M.
What is the long-term trend for AptarGroup's share buybacks?
Over 4 years (2021 to 2025), AptarGroup's share buybacks has grown at a 47.0% compound annual growth rate (CAGR), from $78.15M to $365.01M.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.